In its first years the Mental Health Clinical Research Center (MHCRC) at Yale has established two major core resources to promote and facilitate the development and utilization in clinical psychiatry of sound scientific methodology in research design, behavioral assessment, clinical neuropsychopharmacological measurement, and data analysis. A joint enterprise of the Department of Psychiatry and the Child Study Center, the MHCRC has fostered a developmental perspective in clinical investigation directed at the major psychiatric disorders of the child and the adult. New collaborative initiatives have utilized the core technical resources. We propose to carry the core facilities to a mature stage and to establish specific clinical research areas in childhood neuropsychiatric disorders (autism, Tourette's syndrome, aphasia, and attention deficit disorders); psychosis (schizophrenia); affective disorders; addiction and human genetics. These research areas will constitute core patient facilities and collaborative groups with investigatory expertise for the facilitation of research in major problem areas.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
5P50MH030929-10
Application #
3107015
Study Section
(TDAC)
Project Start
1977-09-29
Project End
1988-08-31
Budget Start
1986-09-01
Budget End
1987-08-31
Support Year
10
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Brand, Theresa; Anderson, George M (2011) The measurement of platelet-poor plasma serotonin: a systematic review of prior reports and recommendations for improved analysis. Clin Chem 57:1376-86
Sukhodolsky, Denis G; Landeros-Weisenberger, Angeli; Scahill, Lawrence et al. (2010) Neuropsychological functioning in children with Tourette syndrome with and without attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 49:1155-64
Epperson, C N; Fasula, D; Wasylink, S et al. (1999) Risperidone addition in serotonin reuptake inhibitor-resistant trichotillomania: three cases. J Child Adolesc Psychopharmacol 9:43-9
Schuldberg, D; Quinlan, D M; Glazer, W (1999) Positive and negative symptoms and and adjustment in severely mentally ill outpatients. Psychiatry Res 85:177-88
Brodkin, E S; McDougle, C J; Naylor, S T et al. (1997) Clomipramine in adults with pervasive developmental disorders: a prospective open-label investigation. J Child Adolesc Psychopharmacol 7:109-21
McDougle, C J; Naylor, S T; Cohen, D J et al. (1996) Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry 53:993-1000
McDougle, C J; Naylor, S T; Cohen, D J et al. (1996) A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry 53:1001-8
Schuldberg, D (1993) Personal resourcefulness: positive aspects of functioning in high-risk research. Psychiatry 56:137-52
Jatlow, P; Nadim, H (1990) Determination of cocaine concentrations in plasma by high-performance liquid chromatography. Clin Chem 36:1436-9
Gillespie, S M; Shaywitz, B A (1987) Neurological manifestations of neurofibromatosis. Conn Med 51:215-9

Showing the most recent 10 out of 17 publications